SecBot SecBot
PRESS-RELEASE ·Filed Apr 7, 2026
CO

COEP

Coeptis Therapeutics
MIXED
Impact 6/10
Horizonweeks Processed6mo ago WireGlobeNewswire
Press release · M&A
Actionable Insight ◆ Mixed

Traders should monitor for closing of the merger in Q2 2026, which will mark a fundamental shift in business model from biopharmaceuticals to cryptocurrency mining. Given the volatility in crypto markets, the new entity’s performance will be highly sensitive to DOGE and LTC prices and mining economics. The rebranding and ticker change to ZSQR signal a complete pivot, which may attract speculative retail interest but also increases regulatory and operational risk.

DirectionMixed
Confidencehigh
Horizonweeks
Latest settled — T+5d
COEP ▲ +18.93% at T+5d
NEUTRAL call +18.93% · α vs SPY +13.60% · entry $10.46 → $12.44
Next anchor: T+20d due 6mo ago
Entry = T+0 close
Apr 7, 2026
via day close
T+1d
+3.73%
call +3.73% · α +1.19%
$10.85
settled 7mo ago
T+5d
+18.93%
call +18.93% · α +13.60%
$12.44
settled 7mo ago
T+20d
Pending
due 6mo ago
T+60d
Pending
due 4mo ago

Price Chart

Loading chart...

Executive Summary

Coeptis Therapeutics announced that Nasdaq has approved the listing of the post-merger company's common stock under the new ticker 'ZSQR', following shareholder approval and the effectiveness of the Form S-4. The merger with Z Squared, Inc.—a digital infrastructure firm focused on Dogecoin and Litecoin mining—is expected to close in Q2 2026. Upon closing, Coeptis will change its name to Z Squared Inc. and become the largest publicly traded pure-play Dogecoin miner in the U.S.

Key Facts

  • Nasdaq has approved the listing of the post-merger entity under ticker 'ZSQR', subject to customary closing conditions.
  • Merger between Coeptis and Z Squared, Inc. remains on track to close in Q2 2026.
  • Shareholder approval and Form S-4 effectiveness have already been achieved.
  • Post-merger, Coeptis will change its name to Z Squared Inc. and operate as a crypto mining-focused company.
  • Z Squared plans to deploy 9,800 ASIC miners across North Carolina, South Carolina, and Iowa, targeting fast conversion of mined assets into USD or stablecoins.

Financial Impact

Strategic transformation from biopharma to crypto mining; no direct dollar value disclosed for the deal itself.

corporate structurebusiness modelrevenue streammarket perception

Risk Factors

  • Merger may not close despite progress due to unsatisfied customary conditions.
  • Shift from biopharma to crypto mining introduces unproven management risk and high exposure to cryptocurrency price volatility.
  • Lack of revenue or earnings data in the release creates uncertainty about financial sustainability post-close.

Market Snapshot

Exchange
Nasdaq
Sector
Finance Services

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3269492

US Market Status

Market Closed — Opens in 9h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 7, 2026